The authors regret an error in the previously reported result concerning the nomenclature of a mutation of APOB gene detected in hypocholesterolemic blood donors. In the text on page e24 in the paragraph 6. ApoB truncations in hypocholeserolemic subjects from the general population we wrote “a carrier of a 6 nucleotide deletion in exon 3 (c.158_163del6) which eliminates two amino acids (threonine at position 26 and tyrosine at position 27 of the mature protein) and introduces an aspartic acid residue with no disruption of the reading frame (Supplementary Table 2 available on line)”. The correct sentence is “a carrier of a six nucleotide deletion in exon 3 (c.158_163del6) which eliminates two amino acids (threonine at position 26 and tyrosine at position 27 of the mature protein) with no disruption of the reading frame (Supplementary Table 2 available on line)”. In the appendix A, Supplementary data, we reported in the first row of Table 2 entitled “Supplementary Table 2. ApoB amino acid changes in hypocholesterolemic blood donors” under the heading “effect on ApoB” the nomenclature Thr26_27delinsAsn. On re-analysis we found that the nomenclature was erroneously reported. The correct designation of the mutation is the following: p.(Thr53_Tyr54del) (Thr26_Tyr27del in the mature protein).
Erratum: Corrigendum to “Molecular diagnosis of hypobetalipoproteinemia: An ENID review” (Atherosclerosis (2007) 192(2) (19–27)(S0021915007003280)(10.1016/j.atherosclerosis.2007.05.003)) / Tarugi, P.; Averna, M.; Di Leo, E.; Cefalu, A. B.; Noto, D.; Magnolo, L.; Cattin, L.; Bertolini, S.; Calandra, S.. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 253:(2016), pp. e1-E1. [10.1016/j.atherosclerosis.2016.05.010]